Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
about
Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?Maintenance treatment with antipsychotic drugs for schizophreniaIntermittent drug techniques for schizophreniaOlanzapine discontinuation for schizophreniaMaintenance treatment with antipsychotic drugs for schizophreniaIntermittent drug techniques for schizophreniaCessation of medication for people with schizophrenia already stable on chlorpromazineSelective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteriaHelping to prioritise interventions for depression and schizophrenia: use of Population Impact MeasuresAntipsychotic drugs in pregnancy: a review of their maternal and fetal effectsHow antipsychotics work-from receptors to reality.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.The Amsterdam Studies of Acute Psychiatry I (ASAP-I); a prospective cohort study of determinants and outcome of coercive versus voluntary treatment interventions in a metropolitan areaThe Sertindole Safety Survey: a retrospective analysis under a named patient use programme in Europe.Neuroleptic discontinuation syndromes.Treatment compliance and noncompliance in psychoses.Prevention of schizophrenia relapse with extended release quetiapine fumarate dosed once daily: a randomized, placebo-controlled trial in clinically stable patients.Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial.Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.Reasoning about the optimal duration of prophylactic antipsychotic medication in schizophrenia: evidence and arguments.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysisMedication-free research in early episode schizophrenia: evidence of long-term harm?Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialAntipsychotic Maintenance Treatment: Time to Rethink?The nature of relapse in schizophrenia.How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials.Perspectives on reasons for non-adherence to medication in persons with schizophrenia in Ethiopia: a qualitative study of patients, caregivers and health workers.Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk.The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis.Psychotropic medication nonadherence among United States Latinos: a comprehensive literature review.High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.Development and application of an aggregate adherence metric derived from population pharmacokinetics to inform clinical trial enrichment.Atypical Antipsychotic Use in the Treatment of Psychosis in Primary CareClinical utilization of atypical antipsychotics in pregnancy and lactation.Recognition of early warning signs in patients with schizophrenia: a review of the literature.
P2860
Q22242820-DAD86F4F-405D-4DF3-9987-BACBC4733367Q24197902-E511A747-8D1B-4451-86FA-F043A8978EE6Q24201124-A00448EA-4F5A-4574-93D0-0BF4508F45FBQ24201521-63C210EE-875F-4B17-AED7-DBD0B3F2BBA2Q24241656-49D6D3DA-0846-4F6E-8BFA-789D1DD0F4A8Q24244627-6256EA80-96FD-498E-8625-F46BF3F83311Q24246474-9EE6F5F2-F467-4180-9F51-8B1EA41F1EB5Q24541080-335636F4-C4F6-4AF8-88FA-E13CC4287FC6Q24547993-91A24A73-E0D5-482D-80C9-0C540477D86CQ26824299-AD4A63A8-365B-4614-B122-34E6C784594AQ30457477-3BB405DD-62E4-44E1-92A2-E76714284C79Q33235110-99FA3D77-908D-4F2D-A05C-91D6CBB7EEEBQ33325634-7F544CFD-3E5D-446E-A6AD-A077E993FAE2Q33334666-E4B77A7A-B772-4E3C-BA31-F90A3827AF5BQ33353040-D2DC8A08-DEA5-41FE-AD1D-2B847925C96AQ33538378-7CBEBB6C-35C5-4C88-82AC-67DD541DE5C0Q33641662-778EB303-DD87-4C45-A188-54369C77FC20Q33814003-19EDCD07-2EF8-4166-BE86-D6FD17751946Q33814201-371C7A1D-2D91-4471-BB93-4058E1361361Q33908794-E1922CD0-4D05-47AE-A4D2-1BF22FF058CCQ33996824-A6B77FC7-284B-4A0F-9A1A-9B77979BADB0Q34075734-CBB8016C-0801-4BF3-8A8E-0E9E23B8EF70Q34254903-C1AD49F2-CEB9-4462-82C9-EA2E56B65EBAQ34266206-E6F6D98B-0C7C-4177-8C77-F38DA89F7174Q34315836-69D5F1D5-CA25-4E66-B87A-2A60EB07F410Q34393431-F903203B-BF51-4678-9CB6-276EDB5CD59CQ34463497-1E4FF427-AE74-45ED-AECA-1E8D26E6F6D1Q34480263-3A2DBE38-1EB8-49C4-9511-95053A660AA8Q34488215-51B65715-0DDA-4385-AE26-9F0B9A1928CFQ34581127-00CE75BE-96A8-4772-9384-0BE1521D4C1CQ34733976-1B7AAC89-6967-4822-A171-0238FFAE556DQ34774899-655D39EB-50CC-47E0-B92B-AA2A5B34A9D9Q35054800-58FD7A49-E7B4-4A05-9E6F-DC7D5E890CE3Q35236574-5376AEF8-342B-487B-85D1-0957077547B8Q35569720-AB0C946B-34E8-46B6-A379-01BD4A741D8DQ35605892-45A745B8-732F-4B68-B1E1-B9389EEFADDBQ35607623-DDE9A168-6A33-4D20-8850-618EB52214CBQ35665593-6C8DB7F7-D2C1-435C-922F-ACBE0472AFC8Q35776755-C418171B-55C1-48D4-A573-06FE96F8C516Q35866453-CB99908B-F2F6-4E78-A0BA-25904575B39E
P2860
Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
@en
type
label
Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
@en
prefLabel
Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
@en
P2093
P1433
P1476
Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1995.03950150005001
P407
P577
1995-03-01T00:00:00Z